Skip to main content

Peer Review reports

From: Efficacy of osimertinib in epidermal growth factor receptor-mutated non-small-cell lung cancer patients with pleural effusion

Original Submission
26 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
12 Jan 2022 Reviewed Reviewer Report
10 Feb 2022 Reviewed Reviewer Report
2 Mar 2022 Author responded Author comments - Hiroshi Nokihara
Resubmission - Version 4
2 Mar 2022 Submitted Manuscript version 4
22 Mar 2022 Reviewed Reviewer Report
20 May 2022 Author responded Author comments - Hiroshi Nokihara
Resubmission - Version 5
20 May 2022 Submitted Manuscript version 5
23 May 2022 Author responded Author comments - Hiroshi Nokihara
Resubmission - Version 6
23 May 2022 Submitted Manuscript version 6
Publishing
26 May 2022 Editorially accepted
1 Jun 2022 Article published 10.1186/s12885-022-09701-2

You can find further information about peer review here.

Back to article page